The Niche

Russian stem-cell firm to go public

Moscow’s Human Stem Cell Institute hopes to break the ice in Russia’s frozen IPO market with a $5 million offering, according to an article in Reuter’s. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE